← Back to Search

Device

A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness (ICVP Trial)

N/A
Waitlist Available
Led By Philip R Troyk, PhD
Research Sponsored by Illinois Institute of Technology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from two-weeks post-op to end of device use, up to 3 years.
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if tiny wireless devices implanted in the brain can help blind people see by sending electrical signals to the brain's vision area.

Eligible Conditions
  • Optic Neuropathy
  • Vision loss
  • Eye Injury
  • Retinitis pigmentosa

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from two-weeks post-op to end of device use, up to 3 years.
This trial's timeline: 3 weeks for screening, Varies for treatment, and from two-weeks post-op to end of device use, up to 3 years. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To test the safety of the WFMA-based cortical interface.
Secondary study objectives
To test the efficacy of the WFMA-based cortical interface

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: WFMA Cortical Visual Prosthesis Single-arm StudyExperimental Treatment1 Intervention
The WFMA is an electronic device that is implanted in the cortical vision processing regions of the brain to produce artificial vision.

Find a Location

Who is running the clinical trial?

Rush University Medical CenterOTHER
439 Previous Clinical Trials
250,241 Total Patients Enrolled
Johns Hopkins UniversityOTHER
2,339 Previous Clinical Trials
14,881,766 Total Patients Enrolled
University of ChicagoOTHER
1,062 Previous Clinical Trials
840,131 Total Patients Enrolled
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,385 Previous Clinical Trials
652,683 Total Patients Enrolled
Illinois Institute of TechnologyLead Sponsor
24 Previous Clinical Trials
15,183 Total Patients Enrolled
The University of Texas at DallasOTHER
67 Previous Clinical Trials
108,102 Total Patients Enrolled
The Chicago LighthouseOTHER
2 Previous Clinical Trials
320 Total Patients Enrolled
Philip R Troyk, PhDPrincipal InvestigatorIllinois Institute of Technology
~1 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top